lipodystrophy syndromes group genetic acquired disorders body unable produce maintain healthy fat medical condition characterized abnormal degenerative conditions bodys adipose tissue specific term lipoatrophy lipo greek fat dystrophy greek abnormal degenerative condition used describing loss fat one area usually face condition also characterized lack circulating leptin may lead osteosclerosis absence fat tissue associated insulin resistance hypertriglyceridemia nonalcoholic fatty liver disease nafld metabolic lipodystrophy divided following congenital lipodystrophy due inherited genetic defect estimated extremely rare possibly affecting one per million acquired lipodystrophy much common especially affecting persons hiv due insufficient capacity subcutaneous adipose tissue store fat fat deposited nonadipose tissue lipotoxicity leading insulin patients display hypertriglyceridemia severe fatty liver disease little adipose average patient lifespan approximately years death liver failure usual cause contrast high levels seen nonalcoholic fatty liver disease associated obesity leptin levels low lipodystrophy lump small dent skin forms person performs injections repeatedly spot types lipodystrophies harmless avoided changing rotating locations injections diabetes using purified insulins may also help one sideeffects lipodystrophy rejection injected medication slowing absorption medication trauma cause bleeding turn reject medication scenarios dosage medication insulin diabetics becomes impossible gauge correctly treatment disease medication administered impaired thereby allowing medical condition worsen cases rotation injection sites may enough prevent lipodystrophy lipodystrophy possible side effect antiretroviral drugs lipodystrophies manifest lipid redistribution excess lack fat various regions body include limited sunken cheeks andor humps back back neck also referred buffalo also exhibits due excess cortisol lipoatrophy commonly seen patients treated thymidine analogue nucleoside reverse transcriptase inhibitors like zidovudine azt stavudine diagnosis clinical diagnosis established experienced endocrinologist genetic confirmation may possible depending subtype partial lipodystrophy patients causative gene using skinfold caliper measure skinfold thickness various parts body total body composition scan using dualenergy xray absorptiometry may help identify dualenergy xray absorptiometry may useful providing regional fat measurements direct visualization fat distribution means fat leptin replacement therapy human recombinant leptin metreleptin shown effective therapy alleviate metabolic complications associated lipodystrophy approved fda treatment generalized lipodystrophy europe based ema metreleptin used addition diet treat lipodystrophy patients loss fatty tissue skin buildup fat elsewhere body liver muscles medicine used adults children age two years generalised lipodystrophy berardinelliseip syndrome lawrence syndrome adults children age years partial lipodystrophy including barraquersimons syndrome standard treatments volanesorsen apociii currently investigated potential therapeutic reduce hypertriglycerides familial partial lipodystrophy patients broaden lipodystrophy united american organization founded run lipodystrophy patients support raise awareness lipodystrophy lipodystrophy uk dedicated uk charity set support people affected march observed world lipodystrophy httpsenwikipediaorgwikilipodystrophy